Device type · QLG
Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QLG
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
120,922
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems
- Product code
- QLG
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1355
- FDA record
- Classification database entry for QLG
Latest FDA decisions
The 8 newest of 9 since 2015.
K222280 · Decided Mar 1, 2023 · 215 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K223537 · Decided Feb 21, 2023 · 90 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K212132 · Decided May 26, 2022 · 322 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K213996 · Decided May 26, 2022 · 157 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K210943 · Decided Nov 22, 2021 · 237 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K211102 · Decided Aug 11, 2021 · 120 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K201761 · Decided Jul 30, 2021 · 396 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
K202145 · Decided May 7, 2021 · 280 days after receipt
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG) · Laboratory Medicine & Pathology
Reports received
120,922
Received Nov 1, 2025 to Nov 19, 2026. Includes 16 of another or unstated type.
Malfunction reports
118,458
98% of reports
Injury reports
2,441
2.0% of reports
Death reports
7
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1,611 | 759 | 0 | 1 |
| Jan 24 | 2,110 | 836 | 2 | 0 |
| Feb 24 | 1,381 | 682 | 1 | 0 |
| Mar 24 | 1,351 | 763 | 1 | 0 |
| Apr 24 | 2,151 | 771 | 0 | 0 |
| May 24 | 2,018 | 819 | 0 | 0 |
| Jun 24 | 1,871 | 859 | 0 | 0 |
| Jul 24 | 2,650 | 1,038 | 0 | 0 |
| Aug 24 | 3,162 | 1,071 | 0 | 0 |
| Sep 24 | 2,501 | 1,012 | 0 | 0 |
| Oct 24 | 2,222 | 953 | 0 | 0 |
| Nov 24 | 1,888 | 693 | 0 | 1 |
| Dec 24 | 1,649 | 659 | 1 | 0 |
| Jan 25 | 1,890 | 483 | 1 | 0 |
| Feb 25 | 1,626 | 371 | 1 | 1 |
| Mar 25 | 1,620 | 355 | 1 | 0 |
| Apr 25 | 1,819 | 321 | 1 | 0 |
| May 25 | 1,712 | 290 | 0 | 0 |
| Jun 25 | 1,733 | 250 | 0 | 0 |
| Jul 25 | 2,107 | 228 | 1 | 0 |
| Aug 25 | 1,387 | 212 | 3 | 0 |
| Sep 25 | 1,196 | 156 | 0 | 0 |
| Oct 25 | 950 | 162 | 0 | 0 |
| Nov 25 | 727 | 143 | 2 | 0 |
| Dec 25 | 603 | 173 | 0 | 0 |
| Jan 26 | 976 | 130 | 0 | 0 |
| Feb 26 | 632 | 123 | 1 | 0 |
| Mar 26 | 1,605 | 139 | 1 | 0 |
| Apr 26 | 2,565 | 232 | 1 | 0 |
| May 26 | 2,141 | 267 | 0 | 0 |
| Jun 26 | 2,310 | 252 | 0 | 0 |
| Jul 26 | 8,807 | 288 | 0 | 1 |
| Aug 26 | 48,099 | 247 | 1 | 14 |
| Sep 26 | 46,687 | 249 | 1 | 0 |
| Oct 26 | 3,306 | 198 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott120,921
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings100,197
- Device Alarm System10,009
- Detachment of Device or Device Component6,432
- Low Readings1,627
- Product Quality Problem771
- Unable to Obtain Readings460
- Delivered as Unsterile Product456
- High Readings444
- Device Displays Incorrect Message443
- Adverse Event Without Identified Device or Use Problem332
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions112,291
- Device Embedded In Tissue or Plaque6,380
- Hypoglycemia885
- Loss of consciousness581
- Hyperglycemia378
- Insufficient Information259
- Diaphoresis208
- Dizziness199
- Fatigue182
- Convulsion/Seizure174
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1020-2026 · Started Nov 24, 2025 · Posted by FDA Jan 14, 2026
Reason given: Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Cause as FDA categorized it: Process control
Z-1021-2026 · Started Nov 24, 2025 · Posted by FDA Jan 14, 2026
Reason given: Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Cause as FDA categorized it: Process control
Z-1022-2026 · Started Nov 24, 2025 · Posted by FDA Jan 14, 2026
Reason given: Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Cause as FDA categorized it: Process control
Z-1023-2026 · Started Nov 24, 2025 · Posted by FDA Jan 14, 2026
Reason given: Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results
Cause as FDA categorized it: Process control
Z-1997-2025 · Started May 21, 2025 · Posted by FDA Jun 20, 2025
Reason given: Due to a software/firmware issue diabetes management system may provide a device error and cause the insulin pen to become unresponsive and unable to function. This error may pose a potential health risk for people living with diabetes as they may not have all information necessary to make a timely treatment decision.
Cause as FDA categorized it: Software design
- FreeStyle Libre 3 Sensors, REF: 72081-01, component of the FreeStyle Libre 3 Continuous Glucose Monitoring SystemOpen, Classified
Z-2692-2024 · Started Jul 24, 2024 · Posted by FDA Aug 27, 2024
Reason given: Users of the FreeStyle Libre 3 sensors reported situations where they were receiving erroneously high glucose results. The inaccurate higher glucose values may lead to users calculating higher insulin bolus correctional doses based on inaccurate CGM glucose data. The inaccurate higher glucose values may also...
Cause as FDA categorized it: Process design
- FreeStyle Libre 2 Readers, REF: 71951-01 and 71953-01, used with FreeStyle Libre 2 SystemOpen, Classified
Z-2414-2023 · Started Jul 12, 2023 · Posted by FDA Aug 17, 2023
Reason given: If blood glucose monitoring system users attempt to start a new sensor, when the old sensor wasn't used for the full 14-day wear time, then the reader may display "Incompatible Sensor" message. If users don't have the previous sensor, or FreeStyle Libre 2 app, or the sensor's full wear time hasn't ended, users may be...
Cause as FDA categorized it: Software Design Change
- FreeStyle Libre Reader, REF: 71951-01, 71952-01, 71953-01 a component of the FreeStyle Libre 2 Flash Glucose Monitoring SystemOpen, Classified
Z-1275-2023 · Started Feb 13, 2023 · Posted by FDA Apr 6, 2023
Reason given: Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the charging cable/power adapter included with readers. Do not use reader if it is damaged, cracked, swelling, too hot to hold, it will no longer hold charge, or it fails Reader Test. Do not use other...
Cause as FDA categorized it: Device Design
Showing the 8 newest of 10 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.